Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot study

BACKGROUND: In patients with suspected heparin-induced thrombocytopenia (HIT) who need renal replacement therapy, a nonheparin anticoagulant has to be chosen to prevent thrombosis in the extracorporeal circuit. Danaparoid, a low-molecular-weight heparinoid consisting of heparan sulphate, dermatan su...

Descripción completa

Detalles Bibliográficos
Autores principales: de Pont, Anne-Cornélie JM, Hofstra, Jorrit-Jan H, Pik, Derk R, Meijers, Joost CM, Schultz, Marcus J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556745/
https://www.ncbi.nlm.nih.gov/pubmed/17854496
http://dx.doi.org/10.1186/cc6119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556745/
https://www.ncbi.nlm.nih.gov/pubmed/17854496
http://dx.doi.org/10.1186/cc6119

Ejemplares similares